Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction product of {mixture of [poly(1~4)chlorosulfonylphthalocyaninato-N29,N30,N31,N32]copper(Ⅱ) and [poly(1~3) chlorosulfonyl (tribenzo[b,g,l]pyrido[2,3-q]-5,10,15,20-tetraazaporphyrinato-N21,N22,N23,N24)] copper(Ⅱ) and [poly(1~2) chlorosulfonyl (dibenzo[b,g(or b,l)]dipyrido [2,3(or 3,2)-l,q(or g,q)]-5,10,15,20-tetraazaporphyrinato-N21,N22,N23,N24)] copper(Ⅱ) and [monochlorosulfonyl (benzo[b]tripyrido [2,3(or 3,2)-g,l,q]-5,10,15,20-tetraazaporphyrinato-N21,N22,N23,N24)]copper(Ⅱ) }and 2-[4-(2-aminoethylamino)-6-(benzylamino)-1,3,5-triazin-2-ylamino]benzene-1,4-disulfonic acid, and ammonia water and sodium chloride
EC number: 700-815-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- aug-oct, 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study has been performed according to OECD guidelines and according to GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: MAFF in Japan (12-Nousan-No. 8147, 2-1-3, 2000)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
Test material
- Reference substance name:
- E-C104
- IUPAC Name:
- E-C104
- Details on test material:
- - Name of test material (as cited in study report): E-C104
- Physical state: blue powder
- Storage condition of test material: under dark condition at room temperature (actual range 20.5-22.3°C)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Tsukuba Breeding Center (Ibaraki, Japan) of Charles River Japan, Inc.
- Age at study initiation: 8 weeks
- Weight at study initiation: 310-331 grams (males); 199-216 grams (females)
- Fasting period before study: not indicated
- Housing: wire-mesh stainless steel cage; during quarantine and acclimatization period, 5 or 2 animals of the same sex were housed in a cage. After selection of animals, 5 animals of the same sex were housed in a cage.
- Diet: pellet diet MF (Oriental Yeast Co., Ltd., Tokyo); ad libitum
- Water: local tap water; ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23±2°C
- Humidity (%): 60±20
- Air changes (per hr): 8
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: August 23, 2011 To: September 27, 2011
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
Animals were individually held in animal holders attached to a snout-only exposure chamber (total volume 31.2 L). The dust was generated by a turn-table type dust feeder with compressed air. The compressed air was supplied to the dust feeder through an air filter. Airflow to the chamber was controlled by an ejector in the dust feeder at a rate of 20 L/min. The chamber air was exhausted through an air filter system consisting of a bag filter, a HEPA filter and an activated charcoal filter. The differential pressure in the chamber was adjusted to and maintained between -20 and -5 mm H2O using exhaust-adjusting valve. Aiflow rate in the dust feeder was continuously confirmed and recorded every 30 minutes during the exposure period.
Nominal concentration: the total amount of active ingredient of the test substance supplied to the chamber was determined gravimetrically with adjustment for the purity. The nominal concentration (mg/L) was calculated by dividing the total amount of active ingredient (mg) by total air volume (L) deliverd during exposure.
Actual concentration: the actual concentration was quantified at 1, 2 and 3 hours after the initiation of exposure. Six litters of chamber air was drawn from the chamber sampling port. The test substance dust was trapped on a pre-weighed glass fiber filter and the amount of the test substance trapped was determined gravimetrically using an electronic balance. The actual concentration (mg/L) was calculated by dividing the amount of the active ingredient (mg) with adjustment for the purity trapped on a glass fiber filter by air volume (L) sampled.
TEST ATMOSPHERE (if not tabulated)
high dose
- Particle size distribution (MMAD): 4.49 µm (4.42-4.60 µm)
- GSD (Geometric st. dev.): 2.34 (2.24-2.51)
- Mean value of actual concentration = >4.99 mg/L (>4.68->5.18)
low dose
- Particle size distribution (MMAD): 4.28 µm (4.12-4.38 µm)
- GSD (Geometric st. dev.): 2.11 (2.09-2.12)
- Mean value of actual concentration = >2.02 mg/L (>1.94->2.11) - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 5 mg/L (m, f), 2 mg/L (m)
- No. of animals per sex per dose:
- high dose: 5m, 5f
low dose: 5m - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observation for mortality and clinical signs at 2 hours after initiation of exposure, immediately, 1 and 4 hours after the exposure, and once daily thereafter until termination of the observation period. Each animal was weighed shortely before the exposure on the day of treatment and when found dead, on 1, 3, 7 and 14 days after exposure.
- Necropsy of survivors performed: yes
- Other examinations performed: none - Statistics:
- The range of LC50 value was determined from the mortality.
Results and discussion
- Preliminary study:
- A dose-finding acute inhalation toxicity study with 1.0 and 5.0 mg/L (E-C104) was performed with 5 rats/sex (study no IET 11-0059). In the 1 mg/L group no mortality was observed during the 7-day observation period, whereas in the 5 mg/L group 1 male and 1 female died at 1 day after exposure. Based on these results, a limit test at 5 mg/L was considered for the main study.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- In the 5 mg/L group 1 male died 4 hours after exposure. No mortality was observed in the 2 mg/L group.
- Clinical signs:
- other: No clinical signs were observed in the low dose group. In the high dose group, sedation, deep respiration and labored respiration until one day after exposure, and disappeared on day 2 after exposure.
- Body weight:
- In the low dose group, body weight lossess were noted in all animals on day 1 after exposure, in 3 males on day 3 after exposure and in 1 male on day 7 after exposure (as compared with body weight before exposure).
In the high dose group, body weight losses were noted in all animals on day 1 after exposure and in 4 males on day 3 after exposure (as compared with body weight before exposure).
All animals gained their body weights at the end of the observation period (14 days after exposure). - Gross pathology:
- No macroscopic abnormalities were noted in any surviving animal at necropsy at the end of the 14-day observation period.
Necropsy of the dead animal in the high dose group showed red color of the lung and foamy fluid in the trachea. - Other findings:
- no
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In the 5 mg/L group, 1 male died on day 1 after snout-only exposure to E-C104 during 4 hours. Based on these results, the LC50 of E-C104 for rats in this study was more than 5 mg/L, and E-C104 needs not to be classified for acute inhalation toxicity according to GHS.
- Executive summary:
The acute inhalation toxicity of E-C104 was tested in Sprague-Dawley rats. Animals were exposed for 4 hours in a snout-only exposure chamber to 5 mg/L (5m, 5f) or 2 mg/L (5m). MMAD and GSD were 4.49 µm and 2.34, respectively (high dose), and 4.28 µm and 2.11, respectively (low dose). In the low dose group, no mortality was observed, whereas 1 male rat died in the high dose group the day after exposure. No clinical signs were observed in the low dose group. In the high dose group, sedation, deep respiration and labored respiration until one day after exposure, which disappeared on day 2 after exposure. In the low dose group, body weight losses were noted in all animals on day 1 after exposure, in 3 males on day 3 after exposure and in 1 male on day 7 after exposure (as compared with body weight before exposure). In the high dose group, body weight losses were noted in all animals on day 1 after exposure and in 4 males on day 3 after exposure (as compared with body weight before exposure). All animals gained their body weights at the end of the observation period (14 days after exposure). No macroscopic abnormalities were noted in any surviving animal at the end of the observation period. Based on these results, The LC50 of E-C104 for both sexes of Sprague-Dawley rats in this study is therefor more than 5 mg/L.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.